Independently researched against Gala GLP-1’s official site, pricing pages, pharmacy and provider disclosures, and public reviews, August 2026. This is a research-based review, not medical advice; we did not personally take prescription medication.
Check current Gala pricing →
What makes Gala different from the other GLP-1 sites
There are dozens of look-alike GLP-1 telehealth brands now, so the useful question isn’t “is Gala good” — it’s “what does Gala do that the others don’t.” Three things stood out to us.
1. It leads with tirzepatide, not semaglutide. Most budget programs push semaglutide (the Ozempic/Wegovy molecule). Gala’s core offer is compounded GLP-1/GIP including tirzepatide — the dual-hormone molecule behind Mounjaro and Zepbound. In clinical trials tirzepatide averaged about 20% body-weight loss over 72 weeks versus roughly 15% for semaglutide, so leading with it is a meaningful difference, not just marketing.
2. There’s a microdosing option. Gala offers a low-dose GLP-1/GIP “longevity protocol” at $149/mo — useful for people who want appetite/metabolic support at a gentler dose, or who’ve finished active weight loss and want maintenance. Few competitors offer this.
3. It’s built for midlife and menopause too. Alongside weight loss, Gala runs a full hormone-health line (estradiol, progesterone, vaginal estradiol, non-hormonal options) plus longevity peptides (NAD+, sermorelin). If your weight gain is tangled up with perimenopause, being able to address both under one provider is a real advantage.
The caveat you should read twice: compounded, not FDA-approved
Gala’s compounded GLP-1/GIP is not an FDA-approved finished drug. It’s prepared by licensed compounding pharmacies using active ingredients from FDA-regulated suppliers, which is legal and common — but it does not carry the FDA’s review for finished-product safety, effectiveness, or manufacturing consistency. Gala is transparent about this in its own FAQ, which we appreciate. If FDA-approved branded medication matters to you, Gala does offer real Ozempic — but at about $1,299/month, versus $149–199 for the compounded route.
What it actually costs
Gala advertises “$179/mo, all doses, no hidden fees,” which is accurate for the compounded track on a yearly plan. Here’s the fuller picture so nothing surprises you at checkout:
| Option | What it is | Price |
|---|---|---|
| Compounded GLP-1/GIP | incl. tirzepatide, standard dosing | from $179/mo (yearly); ~$199/mo on 3-month |
| Microdosing GLP-1/GIP | low-dose longevity protocol | $149/mo |
| Ozempic (brand) | FDA-approved semaglutide | $1,299/mo |
| Hormone / HRT & longevity | estradiol, progesterone, NAD+, sermorelin | priced separately |
No insurance is required, billing is subscription-based, and you can cancel anytime. Dose increases are included at no extra cost — worth noting, because some competitors charge more as you titrate up.
See if you qualify with Gala →
Who’s actually prescribing — and is it legitimate?
This is where Gala scores better than most low-cost brands. Its providers are described as having trained and practiced at Mount Sinai, Harvard Medical School, and Columbia, and medical care is delivered through OpenLoop-affiliated and other independent medical groups (Gala itself provides the technology and administration, not the medical care — a standard, above-board telehealth structure). The platform is LegitScript-certified and HIPAA-compliant, and reports 50,000+ patients with public Trustpilot reviews. Those are the credibility markers we look for before recommending any online prescription service.
Who Gala is a good fit for — and who should look elsewhere
- Specifically want tirzepatide (the stronger dual-hormone option) at a low price
- Are navigating perimenopause/menopause and want weight + hormone care together
- Have a BMI of 30+, or 27+ with a weight-related condition
- Are comfortable with compounded medication and weekly self-injection
Look elsewhere if you: require FDA-approved branded medication specifically (unless you’ll pay ~$1,299/mo for Ozempic); are pregnant or nursing; have a history of medullary thyroid carcinoma, MEN2, or pancreatitis; or want a one-off quick fix rather than a supervised, months-long program paired with lifestyle change.
Pros and cons after our review
- Tirzepatide-first at a very low price ($149–199/mo)
- Microdosing/maintenance option is rare
- Integrated menopause/HRT + longevity care
- Elite-trained providers; LegitScript + HIPAA
- Dose increases included; cancel anytime
- Compounded medication — not FDA-approved
- Lowest price assumes a yearly commitment
- Brand-name option is very expensive
- An initial video visit may be required
- On-site testimonials are hand-selected
Our verdict
For people who’ve already decided a compounded GLP-1 is right for them and want the stronger tirzepatide molecule without paying premium prices, Gala is one of the better-value, better-credentialed options we’ve looked at — a clear 4.5/5. Its menopause/HRT integration is a genuine differentiator most competitors don’t offer. Just go in clear-eyed on the compounded-vs-FDA-approved trade-off, ask your provider the right questions, and treat the medication as one part of a real lifestyle plan.
Start your free Gala assessment →
Frequently asked questions
Is Gala GLP-1 legit?
Yes, by the markers that matter: LegitScript-certified, HIPAA-compliant, care delivered by licensed providers through OpenLoop-affiliated medical groups, with 50,000+ patients and public Trustpilot reviews. The honest caveat is that its lowest-cost medications are compounded, not FDA-approved.
How much does Gala cost?
Compounded GLP-1/GIP (incl. tirzepatide) starts at $179/mo on a yearly plan (about $199/mo on a 3-month plan). Microdosing is $149/mo. Brand-name Ozempic is $1,299/mo. No insurance required, cancel anytime.
Is Gala’s tirzepatide the same as Mounjaro or Zepbound?
It uses the same active ingredient (tirzepatide) but is a compounded formulation, not the FDA-approved branded product. Same molecule, different regulatory status and price.
Does Gala help with menopause weight gain?
Yes — this is one of its differentiators. Gala offers hormone therapy (estradiol, progesterone, non-hormonal options) alongside GLP-1 weight care, so perimenopausal and menopausal patients can address both with one provider.
